{
    "nctId": "NCT04741737",
    "briefTitle": "Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence",
    "officialTitle": "Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence Without Distant Metastasis: A Single-arm, Multicenter, Prospective Study",
    "overallStatus": "RECRUITING",
    "conditions": "Mastectomy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 532,
    "primaryOutcomeMeasure": "5 year disease free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age over 19 years old\n2. Patients who are expected to undergo surgery under the diagnosis of ipsilateral breast tumor recurrence(histologically confirmed in situ disease or invasive disease)\n3. Patients who had partial mastectomy and sentinel lymph node biopsy for prior operation for the initially diagnosed breast cancer\n4. Patients considered to be axillary lymph node negative from clinical findings\n5. Patients who understand and willingly participate in the study\n\nExclusion Criteria:\n\n1. Patients with recurrence in other regions. (e.g. ipsilateral axillary lymph node, supraclavicular lymph node, internal mammary lymph node, etc.)\n2. Patients who are not eligible to perform SLNB\n3. Patients who received mastectomy or axillary lymph node dissection for prior operation\n4. Patients who experienced recurrence within a year from the primary operation\n5. Patientes who are known to have axillary lymph node metastasis before the secondary operation, histologically confirmed from tissue biopsy or cytology\n6. Patients with systemic recurrence\n7. Patients with inflammatory breast cancer\n\n5) Pregnant and lactating patients",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}